Sdi Group PLC
Sdi Group PLC has a market capitalization of £45.11 billion and a price-to-earnings ratio of 11323.51, indicating a high valuation relative to earnings. The company's price-to-book ratio is 908.78, and its enterprise value to EBITDA is 6511.08, suggesting a premium valuation compared to its book value and earnings before interest, taxes, depreciation, and amortization. The company's liquidity position is characterized by a current ratio of 2.09, indicating it has sufficient current assets to cover its current liabilities. In terms of profitability, Sdi Group PLC has a return on equity of 8.03% and a return on assets of 4.52%, which are below the industry median for the Advanced Medical Equipment & Technology sector. The company's operating margin is 10.47% (calculated from operating income of £6.93 million on revenue of £66.18 million), and its net profit margin is 6.02% (calculated from net income of £3.98 million on revenue of £66.18 million). The company's revenue is derived from three main segments: lab equipment, industrial and scientific sensors, and industrial and scientific products. The lab equipment segment includes businesses such as Safelab Systems and Monmouth Scientific, while the industrial and scientific sensors segment includes Chell Instruments and Astles Control Systems. The geographic exposure is not explicitly detailed in the provided data, but the company's operations are primarily in the United Kingdom. Sdi Group PLC's growth trajectory is reflected in its capital expenditure of -£1.88 million, indicating a reduction in capital spending. The company's free cash flow is £6.33 million, suggesting it has the ability to fund operations and potentially return value to shareholders. The company's revenue for the latest period is £66.18 million, and the outlook for the current fiscal year is not explicitly provided in the data. The risk assessment for Sdi Group PLC indicates a medium liquidity risk and a low dilution risk. The company's debt-to-equity ratio is 0.44, and it has a total long-term debt of £21.98 million. The company's net cash position is negative after subtracting total debt, which could impact its liquidity. The company's dilution risk is low, and there are no immediate signs of dilution pressure. Recent events for Sdi Group PLC include analyst estimates with a mean price target of £135.50 and a mean recommendation of 1.50, indicating a generally positive outlook from analysts. The company has one strong-buy recommendation and one buy recommendation, with no hold recommendations.
Business. Sdi Group PLC operates in the healthcare equipment sector, acquiring and developing specialist industrial and scientific products for niche markets including lab equipment, sensors, and scientific instrumentation.
Classification. Sdi Group PLC is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Advanced Medical Equipment & Technology industry with a confidence level of 0.92.
- Sdi Group PLC has a high price-to-earnings ratio, indicating a premium valuation relative to earnings.
- The company's return on equity and return on assets are below the industry median, suggesting lower profitability.
- The company's capital expenditure is negative, indicating a reduction in capital spending.
- Sdi Group PLC has a low dilution risk and a medium liquidity risk.
- Analysts have a generally positive outlook on the company, with a mean price target of £135.50.
- --
- ## RATIONALES
- ```json
- Net cash is negative after subtracting total debt.